Biotech

Sana shares 14-month data for ‘functional cure’ diabetes program

Sana is evaluating a donor-derived primary islet cell therapy designed to serve as a Type 1 diabetes treatment that doesn’t require immunosuppression.

Gabrielle Masson Mar 13, 2026 10:55am

Fierce Biotech Layoff Tracker 2026: Vistagen, Evotec & more

Mar 13, 2026 10:30am

How physiology powers biotech innovation

Brought to you by American Physiological Society

Three stacked cups with coffee spilling out of top one

Inovio trims team as trouble brews at FDA for rare disease drug

Mar 13, 2026 10:03am

Carl Sailer on AI, market trends, and strategic planning in biotech

Brought to you by Syneos Health

Golfer devastated after just barely missing a putt

Immutep's ph. 3 failure surprises analysts, sinks stock

Mar 13, 2026 9:53am